These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 21376325)
1. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia. Nenseter MS; Lindvig HW; Ueland T; Langslet G; Ose L; Holven KB; Retterstøl K Atherosclerosis; 2011 Jun; 216(2):426-32. PubMed ID: 21376325 [TBL] [Abstract][Full Text] [Related]
2. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors]. Real JT; Romero G; Priego MA; Chaves FJ; Ascaso JF; Carmena R An Med Interna; 1999 Feb; 16(2):69-72. PubMed ID: 10192997 [TBL] [Abstract][Full Text] [Related]
3. Concentrations of the atherogenic Lp(a) are elevated in FH. Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014 [TBL] [Abstract][Full Text] [Related]
4. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease. Real JT; Ascaso JF; Chaves FJ; Tenés S; Priego MA; Puig O; Armengod ME; Carmena R Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):41-4. PubMed ID: 10726108 [TBL] [Abstract][Full Text] [Related]
5. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease. Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860 [TBL] [Abstract][Full Text] [Related]
7. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia. Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a), cardiovascular disease, and contemporary management. Jacobson TA Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) determination and risk of cardiovascular disease in South African patients with familial hypercholesterolaemia. Scholtz CL; Lingenhel A; Hillermann R; Stander IA; Kriek JA; Marais MP; Odendaal HJ; Kraft HG; Utermann G; Kotze MJ S Afr Med J; 2000 Apr; 90(4):374-8. PubMed ID: 10957922 [TBL] [Abstract][Full Text] [Related]
10. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
11. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia. Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443 [TBL] [Abstract][Full Text] [Related]
12. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913 [TBL] [Abstract][Full Text] [Related]
13. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. Seed M; Hoppichler F; Reaveley D; McCarthy S; Thompson GR; Boerwinkle E; Utermann G N Engl J Med; 1990 May; 322(21):1494-9. PubMed ID: 2139920 [TBL] [Abstract][Full Text] [Related]
14. Elevated levels of lipoprotein (a) in children with familial hypercholesterolemia. Widhalm K; Genser D Wien Klin Wochenschr; 1994; 106(7):197-200. PubMed ID: 8197753 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation. Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P; J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281 [TBL] [Abstract][Full Text] [Related]
16. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia. Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223 [TBL] [Abstract][Full Text] [Related]
18. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease. Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025 [TBL] [Abstract][Full Text] [Related]
19. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy]. Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189 [TBL] [Abstract][Full Text] [Related]
20. Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia. Tatò F; Keller C; Schuster H; Spengel F; Wolfram G; Zöllner N Atherosclerosis; 1993 Jun; 101(1):69-77. PubMed ID: 8216504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]